A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany

RecruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

December 2, 2024

Primary Completion Date

June 1, 2027

Study Completion Date

May 29, 2029

Conditions

Eosinophilic Esophagitis

Interventions

DRUG

Dupilumab

This study will not administer any treatment, only observe the treatment as prescribed in real-world clinical practice.

Trial Locations (1)

RECRUITING

Investigational Site Number: 0000001, Dachau